Oxford Cancer Analytics
PrivateLast Round
Series A
Jan 9, 2025
Total Funding Raised
$16.46M
Momentum Score
25 /100
Company Overview
Oxford Cancer Analytics is a medtech company that develops liquid biopsy blood tests using advanced proteomics and artificial intelligence for the early detection of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Cancer Analytics Comps
Public and private peers based on sector, stage, and business model.
Oxford Cancer Analytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 9, 2025 | ||||
| Seed | Jan 9, 2023 | ||||
| Seed | Sep 6, 2021 |
Key People
Founding team and executive leadership
Oxford Cancer Analytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| We Venture Capital | Series A |
| Cancer Research UK | Seed |
| The Francis Crick Institute | Seed |
| Cross Border Impact Ventures | Series A |
| DigitalDx Ventures | Series A |
| LifeArc | Seed |
| 青創同行 We Venture | Series A |
Oxford Cancer Analytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oxford Cancer Analytics's valuation, stock price, and market status.
